SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Oliver & Co who wrote (2936)12/3/1997 2:35:00 AM
From: Barron Von Hymen  Read Replies (2) of 6136
 
<<Someone bought today over 4,000 Dec $40 puts>>. If this was purely put buying, that seems to be a extremely high risk trade with not a great reward for such risk. Of course assuming, pure speculation with no inside information, but even inside information sometimes blows up if options expires before your "inside" news becomes public knowledge. Buying the puts, risked approx. $1.2 million that could have went to zero to make 2.8 mill. Could have made the same amount by shorting 312,000 shares, and more safer, because you don't have to worry about expiration within a few weeks as long as the stock didn't explode $10 higher that's less likely.
But definitely begs of an investigation, eh ?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News